skip to Main Content
Get your free newsletter: Actionable insight each morning for self-directed investors. 
Home » UK Shares » Three Quick Facts » Three Quick Facts: Ilika, N4 Pharma and MediaZest

Here are three things you need to know in the financial markets this morning from investment writer, Tony Cross.

Slim pickings across the blue chip stocks for news this morning so we’ll take a quick look at exclusively what’s out from some of the smaller caps.

#1. Ilika completes construction of a clean room

AIM listed Ilika [LON:IKA], the solid state battery specialists, have advised that they have completed the construction of a clean room and advanced various lines of technology acceptance, all of which are necessary for the production of its Stereax battery manufacturing. Testing will continue through calendar Q4, with product qualification in Q1 ‘22  and product sales expected in Q2 ’22.

#2. N4 Pharma provides an operations update

N4 Pharma [LON:N4P], the company working to develop novel delivery systems for cancer treatments and vaccines, has provided an operations update. The work being undertaken to see how these delivery systems can combat COVID-19 are obviously of particular interest given the current climate, and although the note looks like a general round up, it could help lock in recent gains for the stock.

#3. MediaZest sees significant improvement in performance

There’s a trading update out from MediaZest [LON:MDZ], a company which has over the last few months cropped up occasionally on our end of day wrap. As noted in the interim results published for the October-March period, new project work has led to a significant improvement in performance during the second half of the year and the outlook beyond 30th September and into FY 22 also looks encouraging. This is a thinly traded small cap stock and as such can respond dramatically to news updates.

This article is not investment advice. Investors should do their own research or consult a professional advisor.

Tony Cross

Tony Cross

Tony Cross is a market commentator with over 15 years of experience, producing compelling, insightful copy for journalists and investors alike. Focusing on macroeconomics, UK blue chip equities and inter market analysis, Cross's commentary is well regarded for its clarity and ability to cut through the waffle. He has been quoted in publications as diverse as The Financial Times, The Times, The Guardian and The Sun. He has also been a regular guest on both Share Radio and TipTV.

Stocks in Focus

Here are some of the smaller companies we follow most closely. They represent significant growth stories in our view. Our in-depth reports detail why we like them.

Comments

Subscribe for more stories like this, 8am weekdays - for free!


Get your free daily newsletter: 

Thanks to our Partners

Our partners are established, regulated businesses and we are grateful for their support.

Pepperstone
FP Markets
IG
Spreadex
WisdomTree
ActivTrades
Back To Top